PBH Prestige Consumer Healthcare Inc

Price (delayed)

$70.68

Market cap

$3.53B

P/E Ratio

16.79

Dividend/share

N/A

EPS

$4.21

Enterprise value

$4.62B

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio ...

Highlights
The quick ratio has increased by 36% YoY and by 2.1% from the previous quarter
The company's debt fell by 17% YoY and by 6% QoQ

Key stats

What are the main financial stats of PBH
Market
Shares outstanding
49.92M
Market cap
$3.53B
Enterprise value
$4.62B
Valuations
Price to book (P/B)
2.12
Price to sales (P/S)
3.13
EV/EBIT
13.47
EV/EBITDA
12.16
EV/Sales
4.11
Earnings
Revenue
$1.13B
EBIT
$343.19M
EBITDA
$380.01M
Free cash flow
$239.38M
Per share
EPS
$4.21
Free cash flow per share
$4.81
Book value per share
$33.34
Revenue per share
$22.62
TBVPS
$9.45
Balance sheet
Total assets
$3.32B
Total liabilities
$1.66B
Debt
$1.14B
Equity
$1.66B
Working capital
$258M
Liquidity
Debt to equity
0.69
Current ratio
3.2
Quick ratio
1.91
Net debt/EBITDA
2.88
Margins
EBITDA margin
33.8%
Gross margin
55.5%
Net margin
18.6%
Operating margin
30.4%
Efficiency
Return on assets
6.3%
Return on equity
13.4%
Return on invested capital
22.4%
Return on capital employed
10.7%
Return on sales
30.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PBH stock price

How has the Prestige Consumer Healthcare stock price performed over time
Intraday
0.4%
1 week
-0.79%
1 month
2.58%
1 year
10.13%
YTD
15.45%
QTD
2.66%

Financial performance

How have Prestige Consumer Healthcare's revenue and profit performed over time
Revenue
$1.13B
Gross profit
$624.45M
Operating income
$342.43M
Net income
$209.34M
Gross margin
55.5%
Net margin
18.6%

Growth

What is Prestige Consumer Healthcare's growth rate over time

Valuation

What is Prestige Consumer Healthcare stock price valuation
P/E
16.79
P/B
2.12
P/S
3.13
EV/EBIT
13.47
EV/EBITDA
12.16
EV/Sales
4.11
PBH's price to book (P/B) is 17% higher than its 5-year quarterly average of 1.8 and 6% higher than its last 4 quarters average of 2.0
The equity has grown by 14% YoY and by 3.4% from the previous quarter
The price to sales (P/S) is 30% higher than the 5-year quarterly average of 2.4 and 11% higher than the last 4 quarters average of 2.8

Efficiency

How efficient is Prestige Consumer Healthcare business performance

Dividends

What is PBH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PBH.

Financial health

How did Prestige Consumer Healthcare financials performed over time
Prestige Consumer Healthcare's total assets is 100% higher than its total liabilities
The quick ratio has increased by 36% YoY and by 2.1% from the previous quarter
The current ratio is up by 31% year-on-year and by 3.6% since the previous quarter
The company's debt is 31% lower than its equity
Prestige Consumer Healthcare's debt to equity has decreased by 27% YoY and by 9% from the previous quarter
The company's debt fell by 17% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.